Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Advisory

Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024


Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced that it will publish financial results for the fourth quarter and fiscal year 2023 and provide a business update on March 27, 2024.

About Precision BioSciences, Inc.

Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure. Key capabilities and differentiating characteristics may enable ARCUS nucleases to drive more intended, defined therapeutic outcomes. Using ARCUS, the Company's pipeline is comprised of in vivo gene editing candidates designed to deliver lasting cures for the broadest range of genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.


These press releases may also interest you

at 09:53
Product: Meat and vegetable products Issue: Food ? Microbial Contamination ? Listeria Distribution:AlbertaBritish ColumbiaPossibly other provinces and territories See the affected products and product photos for this recall   SOURCE Canadian Food...

at 05:54
Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced the launch of its Customer Experience Center (CEC) in Brazil.  ...

at 00:00
Capital Ophthalmic, a leader in the ophthalmic industry with over four decades of expertise, is proud to announce the launch of their comprehensive Preventative Maintenance Programs. These new offerings underscore Capital Ophthalmic's commitment to...

27 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:AlbertaBritish ColumbiaPossibly other provinces and territories See the affected products and product photos for this recall SOURCE Canadian Food...

27 avr 2024
On April 27 and 28 at San Francisco's Brava Theatre, Chacruna Institute for Psychedelic Plant Medicines will host its unmissable spring conference: Psychedelic Culture. This year's theme is Cultivating Roots for Cultural Change. Registration is still...

27 avr 2024
Product: Gift Chocolate Issue: Food - Allergen - Milk; Food - Allergen - Soy Distribution: Ontario, Quebec See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)



News published on and distributed by: